Recent 8-K filings for OMDA
Highest-materiality recent filing
Omada Health Q2 revenue $88M (+43% YoY), net income $5M; CEO transition to Executive Chair in 2027
- Revenue $88M, up 43% YoY; gross margin 73% (record), up from 66% in Q2 2025.
- Net income $5M vs net loss $5M in Q2 2025; adjusted EBITDA $11M vs loss $0.2M.
-
Omada Health Q2 revenue $88M (+43% YoY), net income $5M; CEO transition to Executive Chair in 2027
Revenue $88M, up 43% YoY; gross margin 73% (record), up from 66% in Q2 2025.
-
Omada Health Q1 revenue $78M (+42% YoY); members top 1M, net loss narrows to $3M
Revenue $78M, up 42% YoY; total members 1.02M, up 51% YoY.
-
Omada Health Q4 revenue $76M (+58% YoY), achieves positive net income of $5M
Q4 revenue $76M (+58% YoY); full-year $260M (+53% YoY). GAAP net income $5M in Q4 vs ($8M) loss prior year.
-
Omada Health reports preliminary Q4 revenue $72-74M, FY 2025 revenue $256-258M
Q4 2025 preliminary revenue $72-74M, up 50-54% YoY; FY 2025 revenue $256-258M, up 51-52%.
-
Omada Health Q3 revenue $68M (+49% YoY); first positive adjusted EBITDA $2M
Revenue $68M, up 49% YoY; members 831K, up 53% YoY.
-
Omada Health Q2 revenue up 49% to $61M; net loss narrows to $5M
Revenue $61M (+49% YoY); members 752K (+52% YoY).
-
Omada Health completes IPO of 9.085M shares at $19.00, raising $172.6M gross
IPO of 9,085,000 shares at $19.00 per share, including full exercise of underwriter option for 1,185,000 shares.
Earnings & guidance
Materiality & sentiment trend
Max materiality 0.85 · Median 0.75 · Most common event earnings